Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha-methyldopa.
D000328:Adult; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D007022:Hypotension / Q000139:chemically induced; D007210:Indoleacetic Acids / Q000652:urine*; D008297:Male; D008750:Methyldopa / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy / Q000652:urine*; D012701:Serotonin / Q000378:metabolism; D014363:Tryptamines / Q000652:urine*
D007210:Indoleacetic Acids; D014363:Tryptamines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008750:Methyldopa